Dementia News and Research

Latest Dementia News and Research

VCP gene mutations cause neurological conditions including IBMPFD and ALS

New research, published in Neuron, gives insight into how single mutations in the VCP gene cause a range of neurological conditions including a form of dementia called Inclusion Body Myopathy, Paget's Disease of the Bone and Frontotemporal Dementia (IBMPFD), and the motor neuron disease Amyotrophic Lateral Sclerosis (ALS).

14 Mar 2013

Research findings could lead to new sleep therapies to improve memory disorders

A team of sleep researchers led by UC Riverside psychologist Sara C. Mednick has confirmed the mechanism that enables the brain to consolidate memory and found that a commonly prescribed sleep aid enhances the process.

13 Mar 2013

Buphenyl may protect memory and prevent progression of Alzheimer's

Buphenyl, an FDA-approved medication for hyperammonemia, may protect memory and prevent the progression of Alzheimer's disease.

12 Mar 2013

Antipsychotic drugs associated with increased risk of stroke in the elderly

Antipsychotic administration in the elderly is associated with an increased risk for cerebrovascular accident, more commonly known as stroke; a new study published in Biological Psychiatry provides additional insight into this important relationship.

12 Mar 2013

Researchers develop new approach to screening potential treatments for Alzheimer's disease

According to a 2012 World Health Organization report, over 35 million people worldwide currently have dementia, a number that is expected to double by 2030 (66 million) and triple by 2050 (115 million).

11 Mar 2013

Animal robots help treat dementia

Proving the benefits and cost-effectiveness of animal robots in the treatment of dementia is the focus of a Griffith research study.

8 Mar 2013

Study shows reduction of brain capillaries in mice immunized with amyloid beta

University of British Columbia researchers have successfully normalized the production of blood vessels in the brain of mice with Alzheimer's disease (AD) by immunizing them with amyloid beta, a protein widely associated with the disease.

8 Mar 2013

UCLA scientists discover new genetic risk factor for Alzheimer's disease

Scientists at UCLA have discovered a new genetic risk factor for Alzheimer's disease by screening people's DNA and then using an advanced type of scan to visualize their brains' connections.

7 Mar 2013

Research illuminates why stimulating environment may protect against Alzheimer's disease

"Use it or lose it." The saying could apply especially to the brain when it comes to protecting against Alzheimer's disease.

7 Mar 2013

Increased blood and oxygen flow to pre-frontal area of brain may explain effects

The resulting increased blood and oxygen flow to the pre-frontal cortex may explain the effects, suggest the researchers.

7 Mar 2013

Vitamin B12 and folate alleviate negative symptoms in patients with schizophrenia

Adding the dietary supplements folate and vitamin B12 to treatment with antipsychotic medication improved a core symptom component of schizophrenia in a study of more than 100 patients.

7 Mar 2013

European scientists find root cause of age-related dementia

A team of European scientists from the University Medical Center Hamburg-Eppendorf and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases at the University of Cologne in Germany has taken an important step closer to understanding the root cause of age-related dementia.

6 Mar 2013

Study identifies how new ALS gene mutations cause other diseases of the brain, muscle and bone

Researchers supported by The ALS Association have discovered how mutations in new amyotrophic lateral sclerosis (ALS) genes cause not only ALS but also other diseases of the brain, muscle and bone.

4 Mar 2013

Shortage of TDP-43 protein causes muscle wasting and stunted nerve cells

A shortage of a protein called TDP-43 caused muscle wasting and stunted nerve cells. This finding supports the idea that malfunction of this protein plays a decisive role in ALS and FTD. The study is published in the "Proceedings of the National Academy of Sciences of the USA" (PNAS).

3 Mar 2013

Remembering proper eating habits can improve physical health and reduce depression

A new analysis has found that a combination of methods that help patients with dementia remember proper eating habits can improve their physical health and lessen symptoms of depression.

1 Mar 2013

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced the U.S. Food and Drug Administration (FDA) has approved ABILIFY MAINTENA (aripiprazole) for extended- release injectable suspension, an intramuscular (IM) depot formulation indicated for the treatment of schizophrenia.

1 Mar 2013

Jones & Bartlett Learning publishes 'Introduction to Neurogenic Communication Disorders'

M. Hunter Manasco, Ph.D., C.C.C.-S.L.P., assistant professor of speech-language pathology at Misericordia University, has had the textbook and video combination, "Introduction to Neurogenic Communication Disorders,'' published by Jones & Bartlett Learning.

28 Feb 2013

Proper eating habits in dementia patients can improve their physical health and lessen symptoms of depression

A new analysis has found that a combination of methods that help patients with dementia remember proper eating habits can improve their physical health and lessen symptoms of depression. Published early online in the Journal of Advanced Nursing, the study indicates that clinicians should consider using this intervention in individuals with dementia who also have poor nutrition and signs of depression.

28 Feb 2013

MID1 complex binds with messenger RNA and controls synthesis of defective Huntingtin

Huntington's disease, also known as Huntington's chorea, is a hereditary brain disease causing movement disorders and dementia. In Germany, there are about 8,000 patients affected by Huntington's disease, with several hundred new cases arising every year. The disease usually manifests between the ages of 35 and 50.

27 Feb 2013

Major doctor group coalition expands list of tests, treatments that should be done only rarely

The American Board of Internal Medicine, as part of its "Choosing Wisely" campaign, expanded the number of medical societies recommending caution before certain tests and procedures are ordered.

22 Feb 2013

Dementia News and Research

Latest Dementia News and Research

VCP gene mutations cause neurological conditions including IBMPFD and ALS

Research findings could lead to new sleep therapies to improve memory disorders

Buphenyl may protect memory and prevent progression of Alzheimer's

Antipsychotic drugs associated with increased risk of stroke in the elderly

Researchers develop new approach to screening potential treatments for Alzheimer's disease

Animal robots help treat dementia

Study shows reduction of brain capillaries in mice immunized with amyloid beta

UCLA scientists discover new genetic risk factor for Alzheimer's disease

Research illuminates why stimulating environment may protect against Alzheimer's disease

Increased blood and oxygen flow to pre-frontal area of brain may explain effects

Vitamin B12 and folate alleviate negative symptoms in patients with schizophrenia

European scientists find root cause of age-related dementia

Study identifies how new ALS gene mutations cause other diseases of the brain, muscle and bone

Shortage of TDP-43 protein causes muscle wasting and stunted nerve cells

Remembering proper eating habits can improve physical health and reduce depression

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Jones & Bartlett Learning publishes 'Introduction to Neurogenic Communication Disorders'

Proper eating habits in dementia patients can improve their physical health and lessen symptoms of depression

MID1 complex binds with messenger RNA and controls synthesis of defective Huntingtin

Major doctor group coalition expands list of tests, treatments that should be done only rarely

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Dementia News and Research

Latest Dementia News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in